Equities

Apollo Hospitals Enterprise Ltd

APOLLOHOSP:NSI

Apollo Hospitals Enterprise Ltd

Actions
Health CareHealth Care Providers
  • Price (INR)6,935.10
  • Today's Change189.15 / 2.80%
  • Shares traded498.63k
  • 1 Year change+25.41%
  • Beta1.0051
Data delayed at least 15 minutes, as of Nov 22 2024 10:15 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in INRIncome statement in INRView more

Year on year Apollo Hospitals Enterprise Ltd grew revenues 14.73% from 166.13bn to 190.59bn while net income improved 9.71% from 8.19bn to 8.99bn.
Gross margin48.41%
Net profit margin5.85%
Operating margin9.90%
Return on assets6.82%
Return on equity16.89%
Return on investment9.37%
More ▼

Cash flow in INRView more

In 2024, Apollo Hospitals Enterprise Ltd increased its cash reserves by 16.64%, or 721.00m. The company earned 19.20bn from its operations for a Cash Flow Margin of 10.08%. In addition the company used 15.37bn on investing activities and also paid 3.11bn in financing cash flows.
Cash flow per share133.18
Price/Cash flow per share52.08
Book value per share521.69
Tangible book value per share441.33
More ▼

Balance sheet in INRView more

Apollo Hospitals Enterprise Ltd has a Debt to Total Capital ratio of 48.22%, a lower figure than the previous year's 58.02%.
Current ratio1.47
Quick ratio1.38
Total debt/total equity0.9827
Total debt/total capital0.4822
More ▼

Growth rates in INR

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 6.67% and 9.71%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Healthcare Facilities industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)0.27%
Div growth rate (5 year)21.67%
Payout ratio (TTM)12.15%
EPS growth(5 years)29.79
EPS (TTM) vs
TTM 1 year ago
69.61
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.